Table 2.
Variable | Crude Est. | Adj. Est. | 2.5% | 97.5% | Adj. P Value |
---|---|---|---|---|---|
Age | −0.35 | 0.169 | –0.355 | 0.693 | .521 |
BMI | 1.64 | 1.610 | 0.851 | 2.370 | .001*** |
Gender (male) | –19.34 | –17.201 | –26.052 | –8.349 | .001*** |
HKAA | 0.26 | –0.372 | –1.411 | 0.666 | .521 |
Lequesne index | 1.25 | 0.858 | –0.416 | 2.131 | .425 |
No metabolic syndrome | –8.49 | –3.871 | –12.659 | 4.916 | .521 |
The model was adjusted for the age, gender, BMI, HKAA, and metabolic syndrome. P values are adjusted. There is a significant positive association of FABP4 levels and BMI and female gender. Crude est. = crude estimate; Adj. est. = adjusted estimate; 2.5% and 97.5% = 2.5% and 97.5% confidence intervals; no metabolic syndrome = patient did not meet metS criteria as outlined in the text; FABP4 = fatty acid binding protein 4; BMI = body mass index; HKAA = hip-knee-ankle angle.